Novartis has agreed to buy Nestle's remaining shares in Alcon ? a 52 percent stake ? for $180 per share, or $28.1 billion. It also has proposed to acquire the remaining 23 percent of shares that it does not already own in exchange for shares, with the intention of merging ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.